β¨ Medicines and Ethics Committee Appointments
4044 NEW ZEALAND GAZETTE, No. 167 19 NOVEMBER 2009
Product:
Itch-Soothe
Active Ingredient:
Crotamiton 10%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Hoe Pharmaceuticals Sdn Bhd, Bandar Sultan Suleiman, Pelabuhan Klang, Selangor, Malaysia
Product:
Zapril
Active Ingredient:
Cilazapril, anhydrous 5mg equivalent to Cilazapril monohydrate 5.22mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals ULC, Etobicoke, Ontario, Canada
Product:
Zapril
Active Ingredient:
Cilazapril, anhydrous 2.5mg equivalent to Cilazapril monohydrate 2.61mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Mylan Pharmaceuticals ULC, Etobicoke, Ontario, Canada
Dated this 13th day of November 2009.
MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go9557
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Kaletra
Active Ingredients:
Lopinavir 100mg
Ritonavir 25mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer:
Abbott GmbH & Co. KG, Ludwigshafen, Germany
Product:
Kaletra
Active Ingredients:
Lopinavir 200mg
Ritonavir 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer:
Abbott GmbH & Co. KG, Ludwigshafen, Germany
Product:
Kaletra
Active Ingredients:
Lopinavir 80mg/mL
Ritonavir 20mg/mL
Dosage Form:
Oral solution
New Zealand Sponsor:
Abbott Laboratories (NZ) Limited
Manufacturer:
Aesica Pharmaceuticals Limited, Queenborough, Kent, United Kingdom
Dated this 13th day of November 2009.
MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go9558
New Zealand Public Health and Disability Act 2000
Appointments to the Upper South B Regional Ethics Committee
Pursuant to Section 11 of the New Zealand Public Health and Disability Act 2000, I appoint
Jan Marsh
Jo Gregan
as members of the Upper South B Regional Ethics Committee for three-year terms of office commencing on the date of this notification; and I also appoint
Patricia Costigan
as chair of the Upper South B Regional Ethics Committee for a three-year term of office commencing on the date of this notification.
Dated at Wellington this 3rd day of November 2009.
HON TONY RYALL, Minister of Health.
go9470
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare13 November 2009
Medicines, Distribution, Consent, Itch-Soothe, Zapril, AFT Pharmaceuticals, Mylan New Zealand, Hoe Pharmaceuticals, Mylan Pharmaceuticals ULC
- MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare13 November 2009
Medicines, Distribution, Consent, Kaletra, Abbott Laboratories, Abbott GmbH & Co. KG, Aesica Pharmaceuticals
- MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Appointments to the Upper South B Regional Ethics Committee
π₯ Health & Social Welfare3 November 2009
Appointments, Ethics Committee, Upper South B, Jan Marsh, Jo Gregan, Patricia Costigan
- Jan Marsh, Appointed member of Upper South B Regional Ethics Committee
- Jo Gregan, Appointed member of Upper South B Regional Ethics Committee
- Patricia Costigan, Appointed chair of Upper South B Regional Ethics Committee
- HON TONY RYALL, Minister of Health
NZ Gazette 2009, No 167